Norepinephrine in the Management of General Anesthesia-Induced Arterial Hypotension in Chronic Heart Failure Patients

Not yet recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions
Hypotension
Interventions
OTHER

Cardiac output monitoring by the Starling™ SV Sebac®

"During the surgery, the channels and monitoring equipment will be set up according to the usual procedure in the vascular surgery department. As part of the research, the Starling™ SV Sebac® electrodes will be installed (to measure cardiac flow, cardiac index (CI), stroke volume (VES), variations in stroke volume (VVES), and peripheral resistors (TPRI)).~Once the equipment is in place, anesthetic induction will be carried out according to the usual protocol with curarization and mechanical ventilation.~If the appearance of arterial hypotension is noted after anesthetic induction and mechanical ventilation, the patient will be definitively included in the study. As recommended, he will receive norepinephrine to treat hypotension.~The measurements from the monitoring will be collected at 3, 5, and 10 min after the administration of norepinephrine.~10 days after admission to the operating room, hospitalization data will be collected."

Trial Locations (1)

31400

CHU Toulouse Rangueil, Toulouse

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT06350929 - Norepinephrine in the Management of General Anesthesia-Induced Arterial Hypotension in Chronic Heart Failure Patients | Biotech Hunter | Biotech Hunter